Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Qiang Du, Bo Wu, Yan-Jun Wang, Sheng Yang, Yue-Yang Zhao & Yuan-yuan Liang. (2013) Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis. Current Medical Research and Opinion 29:11, pages 1487-1494.
Read now
Read now
Articles from other publishers (11)
Laura Banks, Lisa Sparrow, Nicole Sandison, Paul Oh & Tracey J. F. Colella. (2021) The effect of insulin on post-exercise hypoglycemia in adults with type 2 diabetes participating in outpatient exercise-based cardiac rehabilitation. European Journal of Applied Physiology 121:12, pages 3361-3367.
Crossref
Crossref
NesmaAli Ibrahim. (2021) Frequency and predictors of hypoglycemia in Type 2 diabetes: A population-based study. Journal of Diabetology 12:2, pages 157.
Crossref
Crossref
Susanne Jung, Agnes Bosch, Dennis Kannenkeril, Marina V Karg, Kristina Striepe, Peter Bramlage, Christian Ott & Roland E Schmieder. (2020) Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes. European Heart Journal - Cardiovascular Pharmacotherapy 6:6, pages 364-371.
Crossref
Crossref
Brahmanaidu Parim, V. V. Sathibabu Uddandrao & Ganapathy Saravanan. (2018) Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy. Heart Failure Reviews 24:2, pages 279-299.
Crossref
Crossref
Sanjay Kalra, Sarita Bajaj, AG Unnikrishnan, ManashP Baruah, Rakesh Sahay, V Hardik & Amit Kumar. (2019) Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA). Indian Journal of Endocrinology and Metabolism 23:3, pages 312.
Crossref
Crossref
Ratnesh K. SinghEdmund LuiDavid WrightAdrian TaylorMarica Bakovic. (2017)
Alcohol extract of North American ginseng (
Panax quinquefolius
) reduces fatty liver, dyslipidemia, and other complications of metabolic syndrome in a mouse model
. Canadian Journal of Physiology and Pharmacology 95:9, pages 1046-1057.
Crossref
Crossref
Michael Roden, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans J. Woerle & Uli C. Broedl. (2015) Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial. Cardiovascular Diabetology 14:1.
Crossref
Crossref
Chloe L. Edridge, Alison J. Dunkley, Danielle H. Bodicoat, Tanith C. Rose, Laura J. Gray, Melanie J. Davies & Kamlesh Khunti. (2015) Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLOS ONE 10:6, pages e0126427.
Crossref
Crossref
Ganesh R. Kokil, Rakesh N. Veedu, Grant A. Ramm, Johannes B. Prins & Harendra S. Parekh. (2015) Type 2 Diabetes Mellitus: Limitations of Conventional Therapies and Intervention with Nucleic Acid-Based Therapeutics. Chemical Reviews 115:11, pages 4719-4743.
Crossref
Crossref
B. Gallwitz, J. Rosenstock, S. Patel, M. von Eynatten, U. Hehnke, L. Mehlburger, K. A. Dugi & H.-J. Woerle. (2015) Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial. Diabetes, Obesity and Metabolism 17:3, pages 276-284.
Crossref
Crossref
Wenying Yang, Xiaoping Xing, Xiaofeng Lv, Yiming Li, Jianhua Ma, Guoyue Yuan, Feifei Sun, Wei Wang, Michael Woloschak, Valentina Lukashevich, Plamen Kozlovski & Wolfgang Kothny. (2015) Vildagliptin added to sulfonylurea improves glycemic control without hypoglycemia and weight gain in Chinese patients with type 2 diabetes mellitus 中国2型糖尿病患者使用磺脲类药物联合维格列汀可改善血糖控制且无低血糖及体重增加. Journal of Diabetes 7:2, pages 174-181.
Crossref
Crossref